SBI Securities
BBOT icon

SBI Securities’s BridgeBio Oncology BBOT Stock Holding History

SBI Securities’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$767 Buy
+187
New +$1.45K ﹤0.01% 2964

Other funds holding BBOT

Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Toth Financial Advisory
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

SBI Securities's BBOT Position: Q3 2026 in Review

SBI Securities opened a new position in BridgeBio Oncology (BBOT) in Q3 2026: 187 shares worth $767. The stake represents ﹤0.01% of the portfolio and ranks #2964 among its holdings.

4 funds tracked by Wall St. Rank hold BBOT as of Q3 2026.

  • SBI Securities held 187 shares of BridgeBio Oncology worth $767 as of Q3 2026.
  • BridgeBio Oncology was a new SBI Securities position in Q3 2026.
  • BridgeBio Oncology made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2964 holding.
  • 4 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.